Related references
Note: Only part of the references are listed.Epidemiology and aetiology of heart failure
Boback Ziaeian et al.
NATURE REVIEWS CARDIOLOGY (2016)
HUWE1 mutations in Juberg-Marsidi and Brooks syndromes: the results of an X-chromosome exome sequencing study
Michael J. Friez et al.
BMJ OPEN (2016)
Targeting the Ubiquitin-Proteasome System in Heart Disease: The Basis for New Therapeutic Strategies
Oliver Drews et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
H Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase
Stefanie Peter et al.
EMBO MOLECULAR MEDICINE (2014)
The role of ubiquitin ligases in cardiac disease
Monte S. Willis et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
PINK1 Loss-of-Function Mutations Affect Mitochondrial Complex I Activity via NdufA10 Ubiquinone Uncoupling
Vanessa A. Morais et al.
SCIENCE (2014)
Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease
Peter A. Hecker et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Regulation of fetal gene expression in heart failure
Ellen Dirkx et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Cardiac Metabolism and its Interactions With Contraction, Growth, and Survival of Cardiomyocytes
Stephen C. Kolwicz et al.
CIRCULATION RESEARCH (2013)
Role of the Ubiquitin Proteasome System in the Heart
Julia Pagan et al.
CIRCULATION RESEARCH (2013)
Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15
Satoshi Inoue et al.
GENES & DEVELOPMENT (2013)
Metabolic effects of glutamine on the heart: Anaplerosis versus the hexosamine biosynthetic pathway
Benjamin Lauzier et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Loss of PINK1 Increases the Heart's Vulnerability to Ischemia-Reperfusion Injury
Hilary K. Siddall et al.
PLOS ONE (2013)
The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis
Zhenyue Hao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Back to your heart: Ubiquitin proteasome system-regulated signal transduction
Andrea L. Portbury et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Oxidative stress and cardiac hypertrophy: a review
Subir Kumar Maulik et al.
TOXICOLOGY MECHANISMS AND METHODS (2012)
PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function
Filio Billia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice
Preeti Ahuja et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload
Nadia Hedhli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
The HECT family of E3 ubiquitin ligases: Multiple players in cancer development
Francesca Bernassola et al.
CANCER CELL (2008)
Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib
Abdullah Hacihanefioglu et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Metabolic reserve of the heart: The forgotten link between contraction and coronary flow
Christos Kassiotis et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2008)
Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA damage
Jonathan R. Hall et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Unexpected cardiotoxicity in haematological bortezomib treated patients
Enrico Orciuolo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity
Huafeng Zhang et al.
CANCER CELL (2007)
The bitter end - The ubiquitin-proteasome system and cardiac dysfunction
Cam Patterson et al.
CIRCULATION (2007)
Hypertrophic growth in cardiac myocytes is mediated by Myc through a cyclin D2-dependent pathway
Weiguang Zhong et al.
EMBO JOURNAL (2006)
Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis
F Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
ARF-BP1/mule is a critical mediator of the ARF tumor suppressor
DL Chen et al.
CELL (2005)
P38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes
FB Engel et al.
GENES & DEVELOPMENT (2005)
Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: Essential role of the proteasome
SR Powell et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Medical progress: Heart failure
M Jessup et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Proteasome inhibition ablates activation of NF-κB in myocardial reperfusion and reduces reperfusion injury
J Pye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Control of cardiac development by an evolutionarily conserved transcriptional network
RM Cripps et al.
DEVELOPMENTAL BIOLOGY (2002)
E2F1 and c-Myc potentiate apoptosis through inhibition of NF-κB activity that facilitates MnSOD-mediated ROS elimination
H Tanaka et al.
MOLECULAR CELL (2002)
Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis
GS Xiao et al.
CIRCULATION RESEARCH (2001)
Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein
DS Sohal et al.
CIRCULATION RESEARCH (2001)
Share Paper
